- Home
- XNCR vs CTS Comparison
XNCR vs CTS Comparison
Compare XNCR & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- CTS
- Stock Information
- Founded
- XNCR 1997
- CTS 1896
- Country
- XNCR United States
- CTS United States
- Employees
- XNCR N/A
- CTS 4081
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- CTS Electrical Products
- Sector
- XNCR Health Care
- CTS Technology
- Exchange
- XNCR Nasdaq
- CTS Nasdaq
- Market Cap
- XNCR 1.7B
- CTS 1.6B
- IPO Year
- XNCR 2013
- CTS N/A
- Fundamental
- Price
- XNCR $20.45
- CTS $52.84
- Analyst Decision
- XNCR Strong Buy
- CTS Hold
- Analyst Count
- XNCR 9
- CTS 1
- Target Price
- XNCR $36.33
- CTS $46.00
- AVG Volume (30 Days)
- XNCR 766.2K
- CTS 140.2K
- Earning Date
- XNCR 02-25-2025
- CTS 02-04-2025
- Dividend Yield
- XNCR N/A
- CTS 0.31%
- EPS Growth
- XNCR N/A
- CTS 2.12
- EPS
- XNCR N/A
- CTS 1.94
- Revenue
- XNCR $85,164,000.00
- CTS $513,030,000.00
- Revenue This Year
- XNCR N/A
- CTS N/A
- Revenue Next Year
- XNCR $80.86
- CTS $5.85
- P/E Ratio
- XNCR N/A
- CTS $26.62
- Revenue Growth
- XNCR N/A
- CTS N/A
- 52 Week Low
- XNCR $15.31
- CTS $40.92
- 52 Week High
- XNCR $27.24
- CTS $59.68
- Technical
- Relative Strength Index (RSI)
- XNCR 38.80
- CTS 51.98
- Support Level
- XNCR $19.15
- CTS $51.24
- Resistance Level
- XNCR $24.66
- CTS $52.19
- Average True Range (ATR)
- XNCR 1.14
- CTS 1.08
- MACD
- XNCR -0.37
- CTS 0.07
- Stochastic Oscillator
- XNCR 24.96
- CTS 82.37
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan and other countries.